BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 16184580)

  • 1. Early hepatic stellate cell activation is associated with advanced fibrosis after liver transplantation in recipients with hepatitis C.
    Russo MW; Firpi RJ; Nelson DR; Schoonhoven R; Shrestha R; Fried MW
    Liver Transpl; 2005 Oct; 11(10):1235-41. PubMed ID: 16184580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation.
    Carpino G; Morini S; Ginanni Corradini S; Franchitto A; Merli M; Siciliano M; Gentili F; Onetti Muda A; Berloco P; Rossi M; Attili AF; Gaudio E
    Dig Liver Dis; 2005 May; 37(5):349-56. PubMed ID: 15843085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early hepatic stellate cell activation predicts severe hepatitis C recurrence after liver transplantation.
    Gawrieh S; Papouchado BG; Burgart LJ; Kobayashi S; Charlton MR; Gores GJ
    Liver Transpl; 2005 Oct; 11(10):1207-13. PubMed ID: 16184568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic stellate cell immunodetection and cirrhotic evolution of viral hepatitis in liver allografts.
    Guido M; Rugge M; Leandro G; Fiel IM; Thung SN
    Hepatology; 1997 Aug; 26(2):310-4. PubMed ID: 9252139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation.
    Toniutto P; Fabris C; Bitetto D; Falleti E; Avellini C; Rossi E; Smirne C; Minisini R; Pirisi M
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1904-8. PubMed ID: 17914968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated hepatic stellate cells in liver cirrhosis. A morphologic and morphometrical study.
    Carpino G; Franchitto A; Morini S; Corradini SG; Merli M; Gaudio E
    Ital J Anat Embryol; 2004; 109(4):225-38. PubMed ID: 15717457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective evaluation of fibrosis progression in patients with recurrent hepatitis C virus following liver transplantation.
    Yilmaz N; Shiffman ML; Stravitz RT; Sterling RK; Luketic VA; Sanyal AJ; Mills AS; Contos MJ; Coterell A; Maluf D; Posner MP; Fisher RA
    Liver Transpl; 2007 Jul; 13(7):975-83. PubMed ID: 17600360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APRI and FIB-4 Scores Are Useful After Liver Transplantation Independently of Etiology.
    Pissaia A; Borderie D; Bernard D; Scatton O; Calmus Y; Conti F
    Transplant Proc; 2009 Mar; 41(2):679-81. PubMed ID: 19328955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed onset of severe hepatitis C-related liver damage following liver transplantation: a matter of concern?
    Berenguer M; Aguilera V; Prieto M; Carrasco D; Rayón M; San Juan F; Landaverde C; Mir J; Berenguer J
    Liver Transpl; 2003 Nov; 9(11):1152-8. PubMed ID: 14586875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent hepatitis C virus disease after liver transplantation and concurrent biliary tract complications: poor outcome.
    Katz LH; Mor E; Brown M; Bar-Nathan N; Shaharabani E; Sulkes J; Pappo O; Tur-Kaspa R; Ben-Ari Z
    Clin Transplant; 2006; 20(4):465-70. PubMed ID: 16842523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes and hepatic oxidative damage are associated with hepatitis C progression after liver transplantation.
    Cotler SJ; Kallwitz E; TenCate V; Bhushan A; Berkes J; Benedetti E; Layden-Almer J; Layden TJ; Valyi-Nagy T; Guzman G
    Transplantation; 2007 Sep; 84(5):587-91. PubMed ID: 17876270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic stellate cell activation in liver transplant patients with hepatitis C recurrence and in non-transplanted patients with chronic hepatitis C.
    Cisneros L; Londoño MC; Blasco C; Bataller R; Miquel R; Bruguera M; Ginès P; Rimola A
    Liver Transpl; 2007 Jul; 13(7):1017-27. PubMed ID: 17600343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histological and clinical outcome after liver transplantation for hepatitis C.
    Shuhart MC; Bronner MP; Gretch DR; Thomassen LV; Wartelle CF; Tateyama H; Emerson SS; Perkins JD; Carithers RL
    Hepatology; 1997 Dec; 26(6):1646-52. PubMed ID: 9398011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated liver stellate cells in chronic viral C hepatitis: histopathological and immunohistochemical study.
    Tomanovic NR; Boricic IV; Brasanac DC; Stojsic ZM; Delic DS; Brmbolic BJ
    J Gastrointestin Liver Dis; 2009 Jun; 18(2):163-7. PubMed ID: 19565045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple, noninvasive test for the diagnosis of liver fibrosis in patients with hepatitis C recurrence after liver transplantation.
    Cross TJ; Calvaruso V; Foxton MR; Manousou P; Quaglia A; Grillo F; Dhillon AP; Nolan J; Chang TP; O'Grady J; Heneghan MA; O'Beirne JP; Burroughs AK; Harrison PM
    J Viral Hepat; 2010 Sep; 17(9):640-9. PubMed ID: 19922441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are posttransplantation protocol liver biopsies useful in the long term?
    Berenguer M; Rayón JM; Prieto M; Aguilera V; Nicolás D; Ortiz V; Carrasco D; López-Andujar R; Mir J; Berenguer J
    Liver Transpl; 2001 Sep; 7(9):790-6. PubMed ID: 11552213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digital image analysis of liver collagen predicts clinical outcome of recurrent hepatitis C virus 1 year after liver transplantation.
    Manousou P; Dhillon AP; Isgro G; Calvaruso V; Luong TV; Tsochatzis E; Xirouchakis E; Kalambokis G; Cross TJ; Rolando N; O'Beirne J; Patch D; Thornburn D; Burroughs AK
    Liver Transpl; 2011 Feb; 17(2):178-88. PubMed ID: 21280191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GFAP expression in the liver as an early marker of stellate cells activation.
    Morini S; Carotti S; Carpino G; Franchitto A; Corradini SG; Merli M; Gaudio E
    Ital J Anat Embryol; 2005; 110(4):193-207. PubMed ID: 16536051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural history of unexplained chronic hepatitis after liver transplantation.
    Syn WK; Nightingale P; Gunson B; Hubscher SG; Neuberger JM
    Liver Transpl; 2007 Jul; 13(7):984-9. PubMed ID: 17520743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glial fibrillary acidic protein as an early marker of hepatic stellate cell activation in chronic and posttransplant recurrent hepatitis C.
    Carotti S; Morini S; Corradini SG; Burza MA; Molinaro A; Carpino G; Merli M; De Santis A; Muda AO; Rossi M; Attili AF; Gaudio E
    Liver Transpl; 2008 Jun; 14(6):806-14. PubMed ID: 18508359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.